2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions

View by Date

Tuesday, November 10, 2015

9:00AM-11:00AM: Abstract Number: 2224

Tailored, Online Education on Comparative Effectiveness Studies in Rheumatoid Arthritis: Success in Improving Knowledge and Clinical Decisions

Education Poster II

9:00AM-11:00AM: Abstract Number: 3071

Takayasu’s Arteritis and Pregnancy

Vasculitis Poster III

9:00AM-11:00AM: Abstract Number: 3054

Takayasu’s Arteritis Associated with Behçet’s Syndrome: A Case Series of 8 Patients

Vasculitis Poster III

9:00AM-11:00AM: Abstract Number: 2204

Tankyrase Regulates Osteoclastogenesis Via SH3BP2 Expression

Biology and Pathology of Bone and Joint: Bone Remodeling and Metabolism

9:00AM-11:00AM: Abstract Number: 2454

Target and Targetoid Reactions at Bacillus Calmettee-Guérin Inoculation Site Revealed By Dermatoscopy Correlate with Systemic Involvements in Patients with Kawasaki Disease

Pediatric Rheumatology - Clinical and Therapeutic Aspects Posters (ARHP): Pediatrics

9:00AM-11:00AM: Abstract Number: 2677

Targeting Biomarkers of Nitric Oxide and Endothelial Dysfunction in Patients with Rheumatoid Arthritis

Rheumatoid Arthritis - Clinical Aspects Poster Session III

9:00AM-11:00AM: Abstract Number: 2546

Targeting Synovial Fibroblasts By the Intra-Articular Delivery of microRNA-140-3p and -5p Ameliorates Experimental Autoimmune Arthritis

Rheumatoid Arthritis - Animal Models Poster

9:00AM-11:00AM: Abstract Number: 2561

TAS5315, a Novel Bruton’s Tyrosine Kinase (BTK) Inhibitor, Demonstrates Potent Efficacy in an Animal Model of Rheumatoid Arthritis

Rheumatoid Arthritis - Animal Models Poster

9:00AM-11:00AM: Abstract Number: 2222

Teaching Rheumatology in Undergraduate Medical Education: What Are the Students Saying?

Education Poster II

9:00AM-11:00AM: Abstract Number: 2230

Teaching the Teachers: Report of an Effective Mixed-Method Course Training Clinical Educators to Provide Instruction in Musculoskeletal Care to Other Providers and Learners in Primary Care

Education Poster II

9:00AM-11:00AM: Abstract Number: 2495

Tele-Monitoring of Disease Activity in Rheumatoid Arthritis and Psoriatic Arthritis

Quality Measures and Quality of Care Poster Session

9:00AM-11:00AM: Abstract Number: 2496

Telerheumatology: A Technology Not Appropriate for All

Quality Measures and Quality of Care Poster Session

9:00AM-11:00AM: Abstract Number: 2649

Test-Retest Reliability of the 5-Item Compliance Questionnaire Rheumatology and Factors Influencing Its Assessment of Adherence in Patients with Rheumatoid Arthritis

Rheumatoid Arthritis - Clinical Aspects Poster Session III

9:00AM-11:00AM: Abstract Number: 2695

Th17 Cell Related Cytokines and Microarray Expression Profiles in Patients with Early Rheumatoid Arthritis

Rheumatoid Arthritis - Clinical Aspects Poster Session III

9:00AM-11:00AM: Abstract Number: 2608

The “Rheumatoid Arthritis Impact of Disease”� Score Correlates with Other Patient Reported Outcomes and with Disease Activity Scores in Patients with RA and Its Patient Acceptable Symptom State Is More Stringent Than DAS28-Remission

Rheumatoid Arthritis - Clinical Aspects Poster Session III

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].